Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial.

Plain Language Summary

Long-haul air travel increases the occurrence of respiratory illnesses such as the common cold. Elderberries have anti-bacterial and anti-viral properties and previous studies have shown that an elderberry extract can reduce the duration and severity of cold and flu symptoms. This randomised controlled trial aimed to identify whether capsules containing a standardised elderberry extract are effective in preventing respiratory symptoms in travellers on long-haul flights. 325 healthy adults volunteered for the study. Participants were split into two groups: one group was given capsules each containing 300mg of Elderberry extract, and the other group was given placebo capsules. For both groups, participants were given 2 capsules a day for 10 days leading up to travelling, and 3 capsules a day during travel and for four to five days after reaching their destination. Participants completed health surveys 10 days and two days before travelling, and then again five days after. They also kept a daily diary of cold symptoms. Participants in both the placebo and elderberry group tended to experience an increase in respiratory symptoms after travelling. The elderberry group experienced less colds than the placebo group, although the difference was not statistically significant. Elderberry supplementation did however result in a reduction in symptoms, and shortened the cold duration by approximately two days compared to the placebo. The authors recommend that more clinical research with high quality elderberry preparations is carried out to better understand the health benefits of this traditional medicine.